rxstatShortages › Minoxidil

Minoxidil shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Minoxidil products are in shortage in Canada (1 of 5 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 / 5
In shortage since
Apr 11, 2014
Reports on file
14
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
MINOX - LIQ TOP 20MG/ML
20MG · SOLUTION · LABORATOIRE RIVA INC
DIN 02228319 · since Apr 11, 2014, no end estimate · Disruption of the manufacture of the drug.
Anticipated
LONITEN 2.5MG
2.5MG · TABLET · PFIZER CANADA ULC
DIN 00514497 · Disruption of the manufacture of the drug.
Anticipated
LONITEN 10MG
10MG · TABLET · PFIZER CANADA ULC
DIN 00514500 · Disruption of the manufacture of the drug.
Resolved
MEN'S MINOXIDIL FOAM
5% · AEROSOL, FOAM · TARO PHARMACEUTICALS INC
DIN 02551446 · ended Dec 1, 2025 · Disruption of the manufacture of the drug.
Resolved
LONITEN 10MG
10MG · TABLET · PFIZER CANADA ULC
DIN 00514500 · ended Apr 16, 2025 · Demand increase for the drug.
Resolved
LONITEN 2.5MG
2.5MG · TABLET · PFIZER CANADA ULC
DIN 00514497 · ended Feb 28, 2025 · Disruption of the manufacture of the drug.
Resolved
LONITEN 10MG
10MG · TABLET · PFIZER CANADA ULC
DIN 00514500 · ended Oct 31, 2023 · Disruption of the manufacture of the drug.
Resolved
LONITEN 2.5MG
2.5MG · TABLET · PFIZER CANADA ULC
DIN 00514497 · ended Oct 31, 2023 · Disruption of the manufacture of the drug.
Resolved
LONITEN 2.5MG
2.5MG · TABLET · PFIZER CANADA ULC
DIN 00514497 · ended Sep 30, 2022 · Disruption of the manufacture of the drug.
Resolved
LONITEN 10MG
10MG · TABLET · PFIZER CANADA ULC
DIN 00514500 · ended Sep 30, 2022 · Disruption of the manufacture of the drug.
Resolved
LONITEN 2.5MG
2.5MG · TABLET · PFIZER CANADA ULC
DIN 00514497 · ended Oct 1, 2021 · Disruption of the manufacture of the drug.
Discontinued
APO-GAIN LIQ 20MG/ML
20MG · SOLUTION · APOTEX INC
DIN 00885754

Showing 12 of 14 reports. All reports are on file with Health Canada.

What's happening

Minoxidil is currently affected by an active shortage report filed with Health Canada by LABORATOIRE RIVA INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Minoxidil is classified under “ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON” (ATC C02DC).

Recent changes

Common questions

When will Minoxidil be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Minoxidil in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (arteriolarsmooth muscle, agents acting on)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.